Fundraising Fox
Actio Biosciences
3 known investors
Find your way into Actio Biosciences
Sign up to see every warm intro you have to Actio Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Actio Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Actio is a precision medicine company developing therapeutics by leveraging genetic insights to treat rare diseases and common conditions at their molecular root. The company focuses on identifying genes with dysregulated activity and designing therapies to restore normal gene function.
Investors · 3
How we know: Droia Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$66M disclosed across 1 of 2 rounds · 2023–2025
- $66MSeries BJun 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Actio Biosciences do?
- Actio is a precision medicine company developing therapeutics by leveraging genetic insights to treat rare diseases and common conditions at their molecular root. The company focuses on identifying genes with dysregulated activity and designing therapies to restore normal gene function.
- Who are Actio Biosciences's investors?
- Actio Biosciences's investors include Droia Ventures, Canaan Partners, Deerfield Management Company.
- How much funding has Actio Biosciences raised?
- Actio Biosciences has disclosed $66M raised across 1 of its 2 known rounds.